MedTrace Logo

Korean Red Ginseng Rg3 Extract on Arterial Stiffness and Blood Pressure

NCT01951443 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2014-04-28

No results posted yet for this study

Summary

The purpose of the study is to evaluate the acute effect of a standardized extract of KRG (Rg3-KRG) consisting of 30% total ginsenosides, including 10% Rg3 ginsenoside on arterial stiffness and blood pressure, as measured by the following parameters: aortic augmentation index, peripheral blood pressure, central blood pressure

Conditions

  • Arterial Stiffness, Blood Pressure

Interventions

DIETARY_SUPPLEMENT

Ginseng

400mg of encapsulated Rg3-KRG

DIETARY_SUPPLEMENT

Wheat Bran

400mg of encapsulated wheat bran

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Dr. Vladimir Vuksan, PhD · Risk Factor Modification Centre - St. Michael's Hospital

  • Dr. Amir Hanna (Qualified investigator), MD · Unity Health Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01951443 on ClinicalTrials.gov